Every figure on this page comes from documents Lakewood-Amedex Biotherapeutics Inc. filed with the exchange, and each one was checked against the document itself before publication. What could not be verified is not here.
| Quarter | Revenue | YoY | Net profit | YoY | Net margin |
|---|---|---|---|---|---|
| Jun 2026 | — | — | $-4 mn | -475.1% | — |
| Mar 2026 | — | — | $-1 mn | -71.1% | — |
| Jun 2025 | — | — | $-1 mn | — | — |
| Mar 2025 | — | — | $-1 mn | — | — |
Watch it, and each morning it files something you get the checked numbers, the sources, and red-flag alerts when the quiet numbers move — pledges, ratings, resignations. Ask by name any evening and it is read overnight.
Start free — first week on us →Data from documents filed with the exchanges, checked against the documents themselves. This page states facts and is not investment advice or a recommendation. Investment in securities markets is subject to market risks. Research on this site is produced with substantial use of AI and verified against filed documents. Terms, disclosures and grievances